Clinical Trials Browser

Phase 3 × INDUSTRY × Inosine Monophosphate × Clear all

NCT03031938 2021-06-25

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Phase 3 Completed

4 enrolled 78 charts

Cancer Pain, Osteoarthritis, Low Back Pain